HomeAVTR • VIE
Avantor Inc
€11.90
May 15, 5:50:06 PM GMT+2 · EUR · VIE · Disclaimer
StockAT listed securityUS headquartered
Previous close
€11.80
Day range
€11.50 - €12.00
Year range
€10.60 - €25.60
Market cap
8.75B USD
Avg Volume
95.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD)Mar 2025Y/Y change
Revenue
1.58B-5.86%
Operating expense
405.00M-4.46%
Net income
64.50M6.79%
Net profit margin
4.0813.33%
Earnings per share
0.234.55%
EBITDA
229.60M-6.74%
Effective tax rate
24.74%
Total assets
Total liabilities
(USD)Mar 2025Y/Y change
Cash and short-term investments
315.90M24.91%
Total assets
12.33B-3.42%
Total liabilities
6.23B-16.14%
Total equity
6.10B
Shares outstanding
681.43M
Price to book
1.32
Return on assets
2.66%
Return on capital
3.19%
Net change in cash
(USD)Mar 2025Y/Y change
Net income
64.50M6.79%
Cash from operations
109.30M-22.81%
Cash from investing
-28.90M15.50%
Cash from financing
-33.60M74.19%
Net change in cash
53.80M288.77%
Free cash flow
109.31M-14.49%
About
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
Founded
1904
Employees
13,500
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu